Home » Medical Devices » In-Vitro Diagnostics (IVD) Market

In-Vitro Diagnostics (IVD) Market By Product Type (Reagents and Kits, Instruments, Data Management Software); By Technology (Clinical Chemistry, Immunoassay/Immunochemistry, Molecular Diagnostics, Hematology, Coagulation and Hemostasis, Microbiology, Point-of-Care Testing, Others); By Application (Infectious Disease Testing, Oncology/Cancer Testing, Diabetes Testing, Cardiology Testing, Nephrology Testing, Autoimmune Disease Testing, Drug Testing/Pharmacogenomics, Others); By End-User (Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Institutes, Home Care, Others); By Usability (Disposable IVD Devices, Reusable IVD Devices); By Type of Sample (Blood Testing, Urine Testing, Cerebrospinal Fluid Testing, Saliva Testing, Others); By Automation (Fully Automated IVD Systems, Semi-Automated IVD Systems); By Point-of-Care Testing (Glucose Monitoring, Pregnancy and Fertility Testing, Infectious Disease POCT, Cardiac Markers POCT, Others) – Global Forecast, Trends, Size, Share, Growth, and Analysis, 2024-2032

Price: $4999

Published: | Report ID: 6408 | Report Format : PDF
REPORT ATTRIBUTE DETAILS
Historical Period  2019-2022
Base Year  2023
Forecast Period  2024-2032
In-Vitro Diagnostics (IVD) Market Size 2023  USD 117545.8 Million
In-Vitro Diagnostics (IVD) Market, CAGR  5.00%
In-Vitro Diagnostics (IVD) Market Size 2032  USD 182352.1 Million

Market Insights

  • The global demand for In-Vitro Diagnostics (IVD) was valued at USD 117545.8 Million in 2023 and is expected to reach USD 182352.1 Million in 2032, growing at a CAGR of 5.00% between 2024 and 2032.
  • In 2023, the reagents and kits goods category dominated the global market, accounting for more than 65.00% of total revenues. The Instruments category is expected to have the greatest CAGR.
  • The molecular diagnostics application sector retained the biggest market share, while the point-of-care segment is predicted to develop at a significant rate.
  • In 2023, the infectious illness application segment held the most market share. Throughout the forecast period, the oncology application sector is expected to increase rapidly.
  • In 2023, the diagnostic laboratory end-use category led the global market, while hospitals and clinics retained a significant market share.
  • Blood testing is in increasing demand in the In-Vitro Diagnostics (IVD) Market. Another major category is urine testing.
  • Fully automated IVD systems are the most popular segment in the market.
  • The market is seeing increased demand for glucose monitoring, and another key category is infectious disease POCT (Point-of-Care Testing).
  • North America led the global market in 2023, accounting for approximately 41.00% of total revenue. Asia-Pacific is expected to be the fastest expanding geographical market.
  • The popular section is Disposable IVD Devices.
  • The rising prevalence of chronic diseases will fuel market expansion.
  • High instrument costs limit market growth in emerging countries.

In-Vitro Diagnostics (IVD) Market

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Executive Summary

Market Definition

The In-Vitro Diagnostics (IVD) Market is the market for medical equipment and tests that detect diseases, infections, and other medical issues outside of the human body. These tests are carried out on samples such as blood, urine, or tissue and give critical information for medical practitioners to diagnose and monitor disorders. The IVD market offers a diverse range of goods, including laboratory tests, point-of-care testing, and molecular diagnostics. These tests are important in healthcare because they help with early detection, treatment decisions, and illness monitoring.

Market Overview

The global In-Vitro Diagnostics (IVD) Market has witnessed steady growth in recent years and is expected to grow at a CAGR of 5.00% between 2024 and 2032. The market was valued at USD 117545.8 million in 2023 and is expected to reach USD 182352.1 million in 2032.

The In-Vitro Diagnostics (IVD) Market is a fast-growing sector of the healthcare business. It refers to a wide range of medical instruments and tests used to diagnose and monitor diseases. The market is being pushed by factors such as the rising frequency of chronic and infectious diseases, technical advances in diagnostics, and a growing need for individualized medicine. The IVD industry offers a wide variety of products, including immunoassays, molecular diagnostics, clinical chemistry, and point-of-care testing. It is a highly regulated market with strict quality and safety requirements to assure accurate and reliable results. With a growing emphasis on preventive healthcare and early disease identification, the IVD market is likely to continue to expand in the future years.

Segmentation by Product Type

  • In 2023, the reagents and kits products category dominated the global market, accounting for more than 65.00% of total revenues. The region is predicted to maintain its dominance, increasing at the second-fastest CAGR throughout the forecast period, owing to leading market participants’ considerable R&D initiatives for the development of innovative reagents.
  • The Instruments category is predicted to have the highest CAGR.

Segmentation by Technology

  • The molecular diagnostics application segment maintained the largest market share of 40.92% in 2023, owing to the introduction of new products and ongoing technological advancements.
  • The point-of-care segment is expected to grow at a significant rate during the projection period.

Segmentation by Application

  • In 2023, the infectious illness application segment held the largest market share, accounting for 63.66%. IVDs allow for the detection of microorganisms that cause infectious illnesses. The most prevalent life-threatening illnesses include HIV/AIDS, TB, hepatitis, and pneumonia.
  • Throughout the projection period, the oncology application sector is predicted to grow at a high rate.

Segmentation by End-User

  • In 2023, the diagnostic laboratory end-use segment dominated the global market, accounting for more than 41.00% of total revenue. Some of the primary causes projected to improve personalized medicine include increased awareness, increased demand for cheap services, and technology advancements.
  • The hospitals and clinics sector maintained a considerable market share of 36.44% in 2023, owing to an increase in the number of hospitalizations that require speedier diagnostics.

Segmentation by Usability

  • The popular segment is the Disposable IVD Devices. These devices are designed for single-use and are convenient for diagnostic testing, as they eliminate the need for cleaning and sterilization.

Segmentation by Type of Sample

  • Blood testing is in higher demand in the In-Vitro Diagnostics (IVD) Market. Blood tests are widely used for various diagnostic purposes, such as detecting infections, monitoring organ function, and screening for diseases.
  • Another important segment is urine testing, which is commonly used for detecting conditions such as urinary tract infections, kidney diseases, and drug testing.

Segmentation by Automation

  • fully automated IVD systems are the popular segment in the market. These systems are designed to perform a wide range of diagnostic tests with minimal human intervention. They offer efficiency, accuracy, and the ability to handle high volumes of samples, making them highly sought after in healthcare settings.
  • On the other hand, semi-automated IVD systems require more manual intervention and are typically used for specific tests or in smaller laboratories.

Segmentation by Point-of-Care Testing (POCT

  • glucose monitoring is in higher demand in the market. Glucose monitoring is essential for individuals with diabetes to monitor their blood sugar levels regularly. It helps in managing diabetes effectively and making informed decisions about medication, diet, and lifestyle.
  • Another important segment is infectious disease POCT (Point-of-Care Testing).

  Segmentation by Region 

  • North America dominated the global market in 2023, accounting for about 41.00% of total revenue.
  • Asia-Pacific is predicted to be the fastest-growing geographical market.
  • The rest of the world, including Latin America, the Middle East, and Africa, supplies the remaining demand for In-Vitro Diagnostics (IVD).

In-Vitro Diagnostics (IVD) Market Research

North America dominated the global market in 2023. The area is expected to maintain its dominant market position during the forecast period. Factors driving the market in this region include the increased incidence of chronic diseases, a fast growing senior population, high healthcare cost, and supporting government financing. The growing demand for genetic testing for personalized health care, such as diabetes and cancer, is likely to boost market growth in North America.

Moreover, Asia Pacific also had a substantial revenue share of 23.7% in 2023 and is predicted to be the fastest-growing geographical market throughout the projection period. In vitro diagnostic tests are used to diagnose a variety of conditions, including infectious infections, cardiovascular issues, and cancer. A number of reasons are likely to boost the Asia Pacific regional market, including the presence of stabilized economies, quickly rising middle-class populations, supporting government policies, and fast urbanization throughout the area.

Key Highlights of the Report

The global In-Vitro Diagnostics (IVD) Market is segmented by Product Type, Technology, Application, End-User, Type of Sample , Grade, Automation, and region. The molecular diagnostics and infectious illness application segment held the biggest market share, while the Instruments category is expected to have the highest CAGR. Furthermore, the most popular segment is disposable IVD devices, and blood testing is in great demand in the In-Vitro Diagnostics (IVD) Market. Additionally, the hospitals and clinics sector retained a significant market share, with North America leading the market growth.

The market is being driven by the increasing prevalence of chronic and infectious diseases around the world, technological improvements, and growing desire for customized medicine and targeted therapies. Furthermore, strict regulatory regulations and compliance standards for IVD products, high development and commercialization costs, and limited accessibility are the primary limitations of the industry.

Nonetheless, North America led the global market in 2023. The area is likely to continue its dominant market position during the forecast period. Furthermore, Asia Pacific had a significant revenue share of 23.7% in 2023 and is expected to be the fastest-growing geographical market over the forecast period.

What Are The Main Drivers Of The Global In-Vitro Diagnostics (IVD) Market?

The In-Vitro Diagnostics (IVD) Market is driven by several factors. There is an increasing prevalence of chronic and infectious diseases worldwide. This has created a higher demand for diagnostic tests that aid in the early detection and monitoring of these diseases. Also, there have been significant technological advancements in the field of diagnostics, such as molecular diagnostics and point-of-care testing. These advancements have improved the accuracy, speed, and convenience of diagnostic tests, leading to their wider adoption.

What Are The Major Challenges Faced By The Global In-Vitro Diagnostics (IVD) Market?

While the IVD Market shows immense potential, it also faces certain restraints. One of the major challenges is the stringent regulatory requirements and compliance standards for IVD products. These regulations are in place to ensure the safety and efficacy of diagnostic tests, but they can pose significant hurdles for companies seeking to develop and commercialize new technologies. Additionally, the high cost associated with the development and commercialization of advanced diagnostic technologies can be a barrier to entry. The extensive research, clinical trials, and regulatory processes involved in bringing new IVD products to market can be financially burdensome.

What Are The Growth Opportunities In The Global In-Vitro Diagnostics (IVD)Market?

Despite the challenges, the IVD Market presents several opportunities for growth and innovation. there is a significant opportunity for expansion in emerging economies with a growing healthcare infrastructure. As these regions invest in improving their healthcare systems, there will be an increased demand for diagnostic tests to address the rising burden of diseases. Moreover, the Usability of artificial intelligence and data analytics in diagnostics holds great promise. AI algorithms can analyze large datasets and assist in more accurate and efficient diagnosis, leading to improved patient outcomes.

Market Drivers

The global In-Vitro Diagnostics (IVD) Market is driven by several factors. The following are the key drivers of the global In-Vitro Diagnostics (IVD) Market:

Increasing Prevalence Of Chronic Diseases

The increased prevalence of many diseases, including genetic, cardiovascular, and neurological disorders, is putting a huge strain on healthcare. The effective use of IVD in the early detection of such disorders enables doctors to work on relevant treatments more efficiently.

For instance, according to a WHO factsheet from September 2023, Noncommunicable Diseases (NCDs) caused 41 million deaths, accounting for 74% of all deaths worldwide.

Similarly, according to the same source, cardiovascular illnesses are the top cause of death worldwide, killing 17.9 million people each year. This is followed by malignancies (9.3 million), chronic respiratory diseases (4.1 million), and diabetes (2.0 million), which includes renal disease-related deaths from diabetes. These four conditions account for more than 80% of all premature NCD fatalities.

This rising illness load is completely manageable with effective early detection and efficient IVD use at both the patient and clinician levels. Furthermore, the aging population is more vulnerable to a variety of ailments, including hypertension, diabetes, cardiovascular, liver, and kidney disease, which has led to an increase in the usage of homecare intravenous equipment.

Market Restraints

The global In-Vitro Diagnostics (IVD) Market faces some challenges that may hinder its growth. These include the following:

High Cost of Instruments to Limit Market Growth in Emerging Countries

In-vitro diagnostics products have seen considerable gains and developments in terms of further design enhancements during the last decade. However, the high costs of these equipment and their upkeep slowed market growth to some extent.

Furthermore, in-vitro diagnostics tools can only be utilized by trained specialists. This also raises the gadgets’ maintenance costs, stifling overall market growth.

The cost of RT-PCR systems ranges from USD 15,000 to more than USD 90,000. These costs have contributed to the low adoption of in-vitro diagnostics products in numerous nations.

Opportunities

The global In-Vitro Diagnostics (IVD) Market offers significant growth opportunities. These include the following:

Increasing Funding And Government Support For The Development And Innovation Of Devices

Government organizations, groups, and agencies promote the use of IVD by launching awareness campaigns, which drive market growth. WHO published a model list of Essential In-Vitro Diagnostics for primary healthcare and medical facilities with clinical laboratories to help define illness priorities based on burden and prevalence. Both categories are further divided into general IVDs and specific disorders. Furthermore, increased research and government financing are fostering the development of breakthrough items that will move the market forward.

For instance, In June 2023, the European Commission invested around USD 203 million (€ 190.9 million) in the “AGLYC Project”. The goal of this study was to create a first-class blood-based biomarker for detecting ischemia before it caused irreversible cardiac damage. CVD is the major cause of mortality and morbidity around the world, and deploying the AGLYC biomarker is likely to improve patient outcomes.

Similar initiatives and the introduction of new products are projected to propel market expansion in the coming years.

Competitive Landscape

In-Vitro Diagnostics (IVD) Market Report

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key Players

The global In-Vitro Diagnostics (IVD) Market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

  • Invitae Corporation
  • Freenome Holdings, Inc.
  • Natera, Inc.
  • F. Hoffmann-La Roche Ltd.
  • InterVenn Biosciences
  • Guardant Health
  • Agilent Technologies, Inc.
  • Exact Sciences Corporation
  • Illumina, Inc.
  • NeoGenomics Laboratories
  • Thermo Fisher Scientific, Inc.

These organizations prioritize product innovation, In-Vitro Diagnostics (IVD) Centers expansion, and mergers and acquisitions to stay competitive.

The global In-Vitro Diagnostics (IVD) Market’s key players continually seek to stay ahead by offering new products and developments.

In December 2022, BrightInsight Inc. has partnered with bioMérieux to develop and commercialize a clinical digital solution for diagnostics. The technology will provide decision support for disease categories across diagnostic procedures.

In September 2022, BD announced the launch of the BD MAX system in India. The device uses a rapid molecular diagnostic approach to detect MDR-TB and other infectious disorders, allowing clinicians to diagnose TB more quickly.

Summary of Key Findings

  • Expanding the Type of Sample of PLM solutions with LoT systems propels market growth.
  • Market segmented by Product Type, Technology, Application, End-User, Usability, Type of Sample, Automation, Point-of-Care Testing (POCT and region.
  • The most common segment is disposable IVD devices.
  • In 2023, the infectious illness application segment had the greatest market share.
  • North America is leading market growth; the market is highly competitive with key players including Invitae Corporation, Freenome Holdings, Inc., Natera, Inc., F. Hoffmann-La Roche Ltd and Others.

Future Outlook

  • Growing prevalence of chronic and infectious diseases
  • Technological advancements driving innovation in diagnostics
  • Increasing demand for personalized medicine
  • Rising focus on preventive healthcare and early disease detection
  • Stringent quality and safety standards
  • Expansion of point-of-care testing
  • Usability of artificial intelligence and data analytics in diagnostics

How CXOs Can Benefit from the Credence Research In-Vitro Diagnostics (IVD) Market Report

The Credence Research In-Vitro Diagnostics (IVD) Market Report provides CXOs with a comprehensive overview of the market, including:

  • Market size and growth forecast: The report provides detailed estimates of the global In-Vitro Diagnostics (IVD) Market size, segmented by Product Type, Technology, Application, End-User, Usability, Type of Sample, Automation, Point-of-Care Testing (POCT and region. It also includes forecasts for the market through 2032, based on key trends and drivers.
  • Market segmentation: The report segments the In-Vitro Diagnostics (IVD) by Product Type, Technology, Application, End-User, Usability, Type of Sample, Automation, Point-of-Care Testing (POCT and region. This segmentation provides CXOs with a granular understanding of the market and the opportunities in each segment.
  • Competitive landscape: The report profiles the key players in the In-Vitro Diagnostics (IVD) Market and provides insights into their strategies, product offerings, and financial performance. This information can help CXOs to identify and assess their competition.
  • Key trends and drivers: The report identifies and analyzes the key trends and drivers that are shaping the In-Vitro Diagnostics (IVD) Market. This information can help CXOs to make informed decisions about their investments and strategies.

CXOs can use the insights from the Credence Research In-Vitro Diagnostics (IVD) Market Report to:

  • Identify growth opportunities: The report can help CXOs to identify new growth opportunities in the In-Vitro Diagnostics (IVD) Market. For example, the report can provide insights on emerging trends, market dynamics, and competitive landscape in the In-Vitro Diagnostics (IVD) Market.
  • Make informed investment decisions: The report can help CXOs to make informed investment decisions about In-Vitro Diagnostics (IVD). For example, it can provide valuable insights into the current market trends, growth projections, and competitive landscape of the In-Vitro Diagnostics (IVD) industry.
  • Develop competitive strategies: The report can help CXOs to develop competitive strategies for their In-Vitro Diagnostics (IVD) businesses. For example, it offers a deep understanding of market trends, customer preferences, and competitive landscape. CXOs can leverage this information to identify their unique selling points, target specific market segments, and differentiate themselves from competitors.
  • Track market developments: The report can help CXOs to track market developments and stay ahead of the curve. For example, the report provides insights into the latest trends and innovations in the In-Vitro Diagnostics (IVD) Market.

Overall, the Credence Research In-Vitro Diagnostics (IVD) Market Report is a valuable resource for CXOs who are looking to gain a deeper understanding of the market and identify opportunities for growth.

Segmentation

By Product Type:

  • Reagents and Kits
  • Instruments
  • Data Management Software

By Technology:

  • Clinical Chemistry
  • Immunoassay/Immunochemistry
  • Molecular Diagnostics
  • Hematology
  • Coagulation and Hemostasis
  • Microbiology
  • Point-of-Care Testing (POCT)
  • Others

By Application:

  • Infectious Disease Testing
  • Oncology/Cancer Testing
  • Diabetes Testing
  • Cardiology Testing
  • Nephrology Testing
  • Autoimmune Disease Testing
  • Drug Testing/Pharmacogenomics
  • Others

By End-User:

  • Hospitals and Clinics
  • Diagnostic Laboratories
  • Academic and Research Institutes
  • Home Care
  • Others

By Usability:

  • Disposable IVD Devices
  • Reusable IVD Devices

By Type of Sample:

  • Blood Testing
  • Urine Testing
  • Cerebrospinal Fluid (CSF) Testing
  • Saliva Testing
  • Others

By Automation:

  • Fully Automated IVD Systems
  • Semi-Automated IVD Systems

By Point-of-Care Testing (POCT):

  • Glucose Monitoring
  • Pregnancy and Fertility Testing
  • Infectious Disease POCT
  • Cardiac Markers POCT
  • Others
  • By Region
    • North America
      • The U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • The U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • South-east Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East and Africa

Table of Content
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction
2. Executive Summary
2.1. Market Snapshot: Global In-Vitro Diagnostics (IVD) Market
2.1.1. Global In-Vitro Diagnostics (IVD) Market, By Product Type
2.1.2. Global In-Vitro Diagnostics (IVD) Market, By Technology
2.1.3. Global In-Vitro Diagnostics (IVD) Market, By Application
2.1.4. Global In-Vitro Diagnostics (IVD) Market, By End-User
2.1.5. Global In-Vitro Diagnostics (IVD) Market, By Usability
2.1.6. Global In-Vitro Diagnostics (IVD) Market, By Type of Sample
2.1.7. Global In-Vitro Diagnostics (IVD) Market, By Automation
2.1.8. Global In-Vitro Diagnostics (IVD) Market, By
2.1.9. Global In-Vitro Diagnostics (IVD) Market, By Region
2.2. Insights from Primary Respondents
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global In-Vitro Diagnostics (IVD) Market Value, 2017-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. In-Vitro Diagnostics (IVD) Market Drivers
3.2.2. In-Vitro Diagnostics (IVD) Market Restraints
3.2.3. In-Vitro Diagnostics (IVD) Market Opportunities
3.2.4. Major In-Vitro Diagnostics (IVD) Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Product Type
3.5.2. Technology
3.5.3. Application
3.5.4. End-User
3.5.5. Usability
3.5.6. Type of Sample
3.5.7. Automation
3.5.8. Point-of-Care Testing (POCT)
3.5.9. Geography
4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. Global In-Vitro Diagnostics (IVD) Market: Company Market Share, Value 2022
4.1.2. Global In-Vitro Diagnostics (IVD) Market: Top 6 Company Market Share, Value 2022
4.1.3. Global In-Vitro Diagnostics (IVD) Market: Top 3 Company Market Share, Value 2022
4.2. Global In-Vitro Diagnostics (IVD) Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/ SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Product Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Product Matrix
4.7. Potential for New Players in the Global In-Vitro Diagnostics (IVD) Market
5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. Research and development in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis
6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Product Launch
6.5.5. Geographical Expansion
6.5.6. Others
7. Impact Analysis of COVID 19 and Russia – Ukraine War on In-Vitro Diagnostics (IVD) Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Product Mix
7.2.4. Reduced Industrial Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa
8. Global In-Vitro Diagnostics (IVD) Market, By Product Type
8.1. Global In-Vitro Diagnostics (IVD) Market Overview, by Product Type
8.1.1. Global In-Vitro Diagnostics (IVD) Market Revenue Share, By Product Type, 2023 Vs 2032 (in %)
8.2. Reagents and Kits
8.2.1. Global In-Vitro Diagnostics (IVD) Market, By REAGENTS AND KITS, By Region, 2017-2032(US$ Mn)
8.2.2. Market Dynamics for REAGENTS AND KITS
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Instruments
8.3.1. Global In-Vitro Diagnostics (IVD) Market, By INSTRUMENTS, By Region, 2017-2032(US$ Mn)
8.3.2. Market Dynamics for INSTRUMENTS
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
8.4. Data Management Software
8.4.1. Global In-Vitro Diagnostics (IVD) Market, By Data Management Software, By Region, 2017-2032(US$ Mn)
8.4.2. Market Dynamics for Data Management Software
8.4.2.1. Drivers
8.4.2.2. Restraints
8.4.2.3. Opportunities
8.4.2.4. Trends
9. Global In-Vitro Diagnostics (IVD) Market, By Technology
9.1. Global In-Vitro Diagnostics (IVD) Market Overview, by Technology
9.1.1. Global In-Vitro Diagnostics (IVD) Market Revenue Share, By Technology, 2023 Vs 2032 (in %)
9.2. Clinical Chemistry
9.2.1. Global In-Vitro Diagnostics (IVD) Market, By Clinical Chemistry, By Region, 2017-2032(US$ Mn)
9.2.2. Market Dynamics for Clinical Chemistry
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Immunoassay/Immunochemistry
9.3.1. Global In-Vitro Diagnostics (IVD) Market, By Immunoassay/Immunochemistry, By Region, 2017-2032(US$ Mn)
9.3.2. Market Dynamics for Immunoassay/Immunochemistry
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
9.4. Molecular Diagnostics
9.4.1. Global In-Vitro Diagnostics (IVD) Market, By Molecular Diagnostics, By Region, 2017-2032(US$ Mn)
9.4.2. Market Dynamics for Molecular Diagnostics
9.4.2.1. Drivers
9.4.2.2. Restraints
9.4.2.3. Opportunities
9.4.2.4. Trends
9.5. Hematology
9.5.1. Global In-Vitro Diagnostics (IVD) Market, By Hematology, By Region, 2017-2032(US$ Mn)
9.5.2. Market Dynamics for Hematology
9.5.2.1. Drivers
9.5.2.2. Restraints
9.5.2.3. Opportunities
9.5.2.4. Trends
9.6. Coagulation and Hemostasis
9.6.1. Global In-Vitro Diagnostics (IVD) Market, By Coagulation and Hemostasis, By Region, 2017-2032(US$ Mn)
9.6.2. Market Dynamics for Coagulation and Hemostasis
9.6.2.1. Drivers
9.6.2.2. Restraints
9.6.2.3. Opportunities
9.6.2.4. Trends
9.7. Microbiology
9.7.1. Global In-Vitro Diagnostics (IVD) Market, By Microbiology, By Region, 2017-2032(US$ Mn)
9.7.2. Market Dynamics for Microbiology
9.7.2.1. Drivers
9.7.2.2. Restraints
9.7.2.3. Opportunities
9.7.2.4. Trends
9.8. Point-of-Care Testing (POCT)
9.8.1. Global In-Vitro Diagnostics (IVD) Market, By Point-of-Care Testing (POCT), By Region, 2017-2032(US$ Mn)
9.8.2. Market Dynamics for Point-of-Care Testing (POCT)
9.8.2.1. Drivers
9.8.2.2. Restraints
9.8.2.3. Opportunities
9.8.2.4. Trends
9.9. Others
9.9.1. Global In-Vitro Diagnostics (IVD) Market, By Others, By Region, 2017-2032(US$ Mn)
9.9.2. Market Dynamics for Others
9.9.2.1. Drivers
9.9.2.2. Restraints
9.9.2.3. Opportunities
9.9.2.4. Trends
10. Global In-Vitro Diagnostics (IVD) Market, By Application
10.1. Global In-Vitro Diagnostics (IVD) Market Overview, by Application
10.1.1. Global In-Vitro Diagnostics (IVD) Market Revenue Share, By Application, 2023 Vs 2032 (in %)
10.2. Infectious Disease Testing
10.2.1. Global In-Vitro Diagnostics (IVD) Market, By Infectious Disease Testing, By Region, 2017-2032(US$ Mn)
10.2.2. Market Dynamics for Infectious Disease Testing
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Oncology/Cancer Testing
10.3.1. Global In-Vitro Diagnostics (IVD) Market, By Oncology/Cancer Testing, By Region, 2017-2032(US$ Mn)
10.3.2. Market Dynamics for Oncology/Cancer Testing
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends
10.4. Diabetes Testing
10.4.1. Global In-Vitro Diagnostics (IVD) Market, By Diabetes Testing, By Region, 2017-2032(US$ Mn)
10.4.2. Market Dynamics for Diabetes Testing
10.4.2.1. Drivers
10.4.2.2. Restraints
10.4.2.3. Opportunities
10.4.2.4. Trends
10.5. Cardiology Testing
10.5.1. Global In-Vitro Diagnostics (IVD) Market, By Cardiology Testing, By Region, 2017-2032(US$ Mn)
10.5.2. Market Dynamics for Cardiology Testing
10.5.2.1. Drivers
10.5.2.2. Restraints
10.5.2.3. Opportunities
10.5.2.4. Trends
10.6. Nephrology Testing
10.6.1. Global In-Vitro Diagnostics (IVD) Market, By Nephrology Testing, By Region, 2017-2032(US$ Mn)
10.6.2. Market Dynamics for Nephrology Testing
10.6.2.1. Drivers
10.6.2.2. Restraints
10.6.2.3. Opportunities
10.6.2.4. Trends
10.7. Autoimmune Disease Testing
10.7.1. Global In-Vitro Diagnostics (IVD) Market, By Autoimmune Disease Testing, By Region, 2017-2032(US$ Mn)
10.7.2. Market Dynamics for Autoimmune Disease Testing
10.7.2.1. Drivers
10.7.2.2. Restraints
10.7.2.3. Opportunities
10.7.2.4. Trends
10.8. Drug Testing/Pharmacogenomics
10.8.1. Global In-Vitro Diagnostics (IVD) Market, By Drug Testing/Pharmacogenomics, By Region, 2017-2032(US$ Mn)
10.8.2. Market Dynamics for Drug Testing/Pharmacogenomics
10.8.2.1. Drivers
10.8.2.2. Restraints
10.8.2.3. Opportunities
10.8.2.4. Trends
10.9. Others
10.9.1. Global In-Vitro Diagnostics (IVD) Market, By Others, By Region, 2017-2032(US$ Mn)
10.9.2. Market Dynamics for Others
10.9.2.1. Drivers
10.9.2.2. Restraints
10.9.2.3. Opportunities
10.9.2.4. Trends
11. Global In-Vitro Diagnostics (IVD) Market, By End-User
11.1. Global In-Vitro Diagnostics (IVD) Market Overview, by End-User
11.1.1. Global In-Vitro Diagnostics (IVD) Market Revenue Share, By End-User, 2023 Vs 2032 (in %)
11.2. Hospitals and Clinics
11.2.1. Global In-Vitro Diagnostics (IVD) Market, By Hospitals and Clinics, By Region, 2017-2032(US$ Mn)
11.2.2. Market Dynamics for Hospitals and Clinics
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
11.3. Diagnostic Laboratories
11.3.1. Global In-Vitro Diagnostics (IVD) Market, By Diagnostic Laboratories, By Region, 2017-2032(US$ Mn)
11.3.2. Market Dynamics for Diagnostic Laboratories
11.3.2.1. Drivers
11.3.2.2. Restraints
11.3.2.3. Opportunities
11.3.2.4. Trends
11.4. Academic and Research Institutes
11.4.1. Global In-Vitro Diagnostics (IVD) Market, By Academic and Research Institutes, By Region, 2017-2032(US$ Mn)
11.4.2. Market Dynamics for Academic and Research Institutes
11.4.2.1. Drivers
11.4.2.2. Restraints
11.4.2.3. Opportunities
11.4.2.4. Trends
11.5. Home Care
11.5.1. Global In-Vitro Diagnostics (IVD) Market, By Home Care, By Region, 2017-2032(US$ Mn)
11.5.2. Market Dynamics for Home Care
11.5.2.1. Drivers
11.5.2.2. Restraints
11.5.2.3. Opportunities
11.5.2.4. Trends
11.6. Others
11.6.1. Global In-Vitro Diagnostics (IVD) Market, By Others, By Region, 2017-2032(US$ Mn)
11.6.2. Market Dynamics for Others
11.6.2.1. Drivers
11.6.2.2. Restraints
11.6.2.3. Opportunities
11.6.2.4. Trends
12. Global In-Vitro Diagnostics (IVD) Market, By Usability
12.1. Global In-Vitro Diagnostics (IVD) Market Overview, by Usability
12.1.1. Global In-Vitro Diagnostics (IVD) Market Revenue Share, By Usability, 2023 Vs 2032 (in %)
12.2. Disposable IVD Devices
12.2.1. Global In-Vitro Diagnostics (IVD) Market, By Disposable IVD Devices, By Region, 2017-2032(US$ Mn)
12.2.2. Market Dynamics for Disposable IVD Devices
12.2.2.1. Drivers
12.2.2.2. Restraints
12.2.2.3. Opportunities
12.2.2.4. Trends
12.3. Reusable IVD Devices
12.3.1. Global In-Vitro Diagnostics (IVD) Market, By Reusable IVD Devices, By Region, 2017-2032(US$ Mn)
12.3.2. Market Dynamics for Reusable IVD Devices
12.3.2.1. Drivers
12.3.2.2. Restraints
12.3.2.3. Opportunities
12.3.2.4. Trends
13. Global In-Vitro Diagnostics (IVD) Market, By Type of Sample
13.1. Global In-Vitro Diagnostics (IVD) Market Overview, by Type of Sample
13.1.1. Global In-Vitro Diagnostics (IVD) Market Revenue Share, By Type of Sample, 2023 Vs 2032 (in %)
13.2. Blood Testing
13.2.1. Global In-Vitro Diagnostics (IVD) Market, By Blood Testing, By Region, 2017-2032(US$ Mn)
13.2.2. Market Dynamics for Blood Testing
13.2.2.1. Drivers
13.2.2.2. Restraints
13.2.2.3. Opportunities
13.2.2.4. Trends
13.3. Urine Testing
13.3.1. Global In-Vitro Diagnostics (IVD) Market, By Urine Testing, By Region, 2017-2032(US$ Mn)
13.3.2. Market Dynamics for Urine Testing
13.3.2.1. Drivers
13.3.2.2. Restraints
13.3.2.3. Opportunities
13.3.2.4. Trends
13.4. Cerebrospinal Fluid (CSF) Testing
13.4.1. Global In-Vitro Diagnostics (IVD) Market, By Cerebrospinal Fluid (CSF) Testing, By Region, 2017-2032(US$ Mn)
13.4.2. Market Dynamics for Cerebrospinal Fluid (CSF) Testing
13.4.2.1. Drivers
13.4.2.2. Restraints
13.4.2.3. Opportunities
13.4.2.4. Trends
13.5. Saliva Testing
13.5.1. Global In-Vitro Diagnostics (IVD) Market, By Saliva Testing, By Region, 2017-2032(US$ Mn)
13.5.2. Market Dynamics for Saliva Testing
13.5.2.1. Drivers
13.5.2.2. Restraints
13.5.2.3. Opportunities
13.5.2.4. Trends
13.6. Others
13.6.1. Global In-Vitro Diagnostics (IVD) Market, By Others, By Region, 2017-2032(US$ Mn)
13.6.2. Market Dynamics for Others
13.6.2.1. Drivers
13.6.2.2. Restraints
13.6.2.3. Opportunities
13.6.2.4. Trends
14. Global In-Vitro Diagnostics (IVD) Market, By Automation
14.1. Global In-Vitro Diagnostics (IVD) Market Overview, by Automation
14.1.1. Global In-Vitro Diagnostics (IVD) Market Revenue Share, By Automation, 2023 Vs 2032 (in %)
14.2. Fully Automated IVD Systems
14.2.1. Global In-Vitro Diagnostics (IVD) Market, By Fully Automated IVD Systems, By Region, 2017-2032(US$ Mn)
14.2.2. Market Dynamics for Fully Automated IVD Systems
14.2.2.1. Drivers
14.2.2.2. Restraints
14.2.2.3. Opportunities
14.2.2.4. Trends
14.3. Semi-Automated IVD Systems
14.3.1. Global In-Vitro Diagnostics (IVD) Market, By Semi-Automated IVD Systems, By Region, 2017-2032(US$ Mn)
14.3.2. Market Dynamics for Semi-Automated IVD Systems
14.3.2.1. Drivers
14.3.2.2. Restraints
14.3.2.3. Opportunities
14.3.2.4. Trends
15. Global In-Vitro Diagnostics (IVD) Market, By Point-of-Care Testing (POCT)
15.1. Global In-Vitro Diagnostics (IVD) Market Overview, by Point-of-Care Testing (POCT)
15.1.1. Global In-Vitro Diagnostics (IVD) Market Revenue Share, By Point-of-Care Testing (POCT), 2023 Vs 2032 (in %)
15.2. Glucose Monitoring
15.2.1. Global In-Vitro Diagnostics (IVD) Market, By Glucose Monitoring, By Region, 2017-2032(US$ Mn)
15.2.2. Market Dynamics for Glucose Monitoring
15.2.2.1. Drivers
15.2.2.2. Restraints
15.2.2.3. Opportunities
15.2.2.4. Trends
15.3. Pregnancy and Fertility Testing
15.3.1. Global In-Vitro Diagnostics (IVD) Market, By Pregnancy and Fertility Testing, By Region, 2017-2032(US$ Mn)
15.3.2. Market Dynamics for Pregnancy and Fertility Testing
15.3.2.1. Drivers
15.3.2.2. Restraints
15.3.2.3. Opportunities
15.3.2.4. Trends
15.4. Infectious Disease POCT
15.4.1. Global In-Vitro Diagnostics (IVD) Market, By Infectious Disease POCT, By Region, 2017-2032(US$ Mn)
15.4.2. Market Dynamics for Infectious Disease POCT
15.4.2.1. Drivers
15.4.2.2. Restraints
15.4.2.3. Opportunities
15.4.2.4. Trends
15.5. Cardiac Markers POCT
15.5.1. Global In-Vitro Diagnostics (IVD) Market, By Cardiac Markers POCT, By Region, 2017-2032(US$ Mn)
15.5.2. Market Dynamics for Cardiac Markers POCT
15.5.2.1. Drivers
15.5.2.2. Restraints
15.5.2.3. Opportunities
15.5.2.4. Trends
15.6. Others
15.6.1. Global In-Vitro Diagnostics (IVD) Market, By Others, By Region, 2017-2032(US$ Mn)
15.6.2. Market Dynamics for Others
15.6.2.1. Drivers
15.6.2.2. Restraints
15.6.2.3. Opportunities
15.6.2.4. Trends
16. Global In-Vitro Diagnostics (IVD) Market, By Region
16.1. Global In-Vitro Diagnostics (IVD) Market Overview, by Region
16.1.1. Global In-Vitro Diagnostics (IVD) Market, By Region, 2023 Vs 2032 (in%)
16.2. Product Type
16.2.1. Global In-Vitro Diagnostics (IVD) Market, By Product Type, 2017-2032(US$ Mn)
16.3. Technology
16.3.1. Global In-Vitro Diagnostics (IVD) Market, By Technology, 2017-2032(US$ Mn)
16.4. Application
16.4.1. Global In-Vitro Diagnostics (IVD) Market, By Application, 2017-2032(US$ Mn)
16.5. End-User
16.5.1. Global In-Vitro Diagnostics (IVD) Market, By End-User, 2017-2032(US$ Mn)
16.6. Usability
16.6.1. Global In-Vitro Diagnostics (IVD) Market, By Usability, 2017-2032(US$ Mn)
16.7. Type of Sample
16.7.1. Global In-Vitro Diagnostics (IVD) Market, By Type of Sample, 2017-2032(US$ Mn)
16.8. Automation
16.8.1. Global In-Vitro Diagnostics (IVD) Market, By Automation, 2017-2032(US$ Mn)
16.9. Point-of-Care Testing (POCT)
16.9.1. Global In-Vitro Diagnostics (IVD) Market, By 16.9. Point-of-Care Testing (POCT), 2017-2032(US$ Mn)
17. North America In-Vitro Diagnostics (IVD) Market Analysis
17.1. Overview
17.1.1. Market Dynamics for North America
17.1.1.1. Drivers
17.1.1.2. Restraints
17.1.1.3. Opportunities
17.1.1.4. Trends
17.2. North America In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2030(US$ Mn)
17.2.1. Overview
17.2.2. SRC Analysis
17.3. North America In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2030(US$ Mn)
17.3.1. Overview
17.3.2. SRC Analysis
17.4. North America In-Vitro Diagnostics (IVD) Market, by Application, 2017-2030(US$ Mn)
17.4.1. Overview
17.4.2. SRC Analysis
17.5. North America In-Vitro Diagnostics (IVD) Market, by End-User, 2017-2030(US$ Mn)
17.5.1. Overview
17.5.2. SRC Analysis
17.6. North America In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2030(US$ Mn)
17.6.1. Overview
17.6.2. SRC Analysis
17.7. North America In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2030(US$ Mn)
17.7.1. Overview
17.7.2. SRC Analysis
17.8. North America In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2030(US$ Mn)
17.8.1. Overview
17.8.2. SRC Analysis
17.9. North America In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2030(US$ Mn)
17.9.1. Overview
17.9.2. SRC Analysis
17.10. North America In-Vitro Diagnostics (IVD) Market, by Country, 2017-2030(US$ Mn)
17.10.1. North America In-Vitro Diagnostics (IVD) Market, by Country, 2023 Vs 2032 (in%)
17.10.2. U.S.
17.10.3. Canada
17.10.4. Mexico
18. Europe In-Vitro Diagnostics (IVD) Market Analysis
18.1. Overview
18.1.1. Market Dynamics for North America
18.1.1.1. Drivers
18.1.1.2. Restraints
18.1.1.3. Opportunities
18.1.1.4. Trends
18.2. Europe In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2030(US$ Mn)
18.2.1. Overview
18.2.2. SRC Analysis
18.3. Europe In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2030(US$ Mn)
18.3.1. Overview
18.3.2. SRC Analysis
18.4. Europe In-Vitro Diagnostics (IVD) Market, by Application, 2017-2030(US$ Mn)
18.4.1. Overview
18.4.2. SRC Analysis
18.5. Europe In-Vitro Diagnostics (IVD) Market, by End-User, 2017-2030(US$ Mn)
18.5.1. Overview
18.5.2. SRC Analysis
18.6. Europe In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2030(US$ Mn)
18.6.1. Overview
18.6.2. SRC Analysis
18.7. Europe In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2030(US$ Mn)
18.7.1. Overview
18.7.2. SRC Analysis
18.8. Europe In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2030(US$ Mn)
18.8.1. Overview
18.8.2. SRC Analysis
18.9. Europe In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2030(US$ Mn)
18.9.1. Overview
18.9.2. SRC Analysis
18.10. Europe In-Vitro Diagnostics (IVD) Market, by Country, 2017-2032(US$ Mn)
18.10.1. Europe In-Vitro Diagnostics (IVD) Market, by Country, 2023 Vs 2032 (in%)
18.10.2. UK
18.10.3. France
18.10.4. Germany
18.10.5. Italy
18.10.6. Spain
18.10.7. Benelux
18.10.8. Russia
18.10.9. Rest of Europe
19. Asia Pacific In-Vitro Diagnostics (IVD) Market Analysis
19.1. Overview
19.1.1. Market Dynamics for North America
19.1.1.1. Drivers
19.1.1.2. Restraints
19.1.1.3. Opportunities
19.1.1.4. Trends
19.2. Asia Pacific In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2030(US$ Mn)
19.2.1. Overview
19.2.2. SRC Analysis
19.3. Asia Pacific In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2030(US$ Mn)
19.3.1. Overview
19.3.2. SRC Analysis
19.4. Asia Pacific In-Vitro Diagnostics (IVD) Market, by Application, 2017-2030(US$ Mn)
19.4.1. Overview
19.4.2. SRC Analysis
19.5. Asia Pacific In-Vitro Diagnostics (IVD) Market, by End-User, 2017-2030(US$ Mn)
19.5.1. Overview
19.5.2. SRC Analysis
19.6. Asia Pacific In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2030(US$ Mn)
19.6.1. Overview
19.6.2. SRC Analysis
19.7. Asia Pacific In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2030(US$ Mn)
19.7.1. Overview
19.7.2. SRC Analysis
19.8. Asia Pacific In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2030(US$ Mn)
19.8.1. Overview
19.8.2. SRC Analysis
19.9. Asia Pacific In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2030(US$ Mn)
19.9.1. Overview
19.9.2. SRC Analysis
19.10. Asia Pacific In-Vitro Diagnostics (IVD) Market, by Country, 2017-2032(US$ Mn)
19.10.1. Asia Pacific In-Vitro Diagnostics (IVD) Market, by Country, 2023 Vs 2032 (in%)
19.10.2. China
19.10.3. Japan
19.10.4. India
19.10.5. South Korea
19.10.6. South East Asia
19.10.7. Rest of Asia Pacific
20. Latin America In-Vitro Diagnostics (IVD) Market Analysis
20.1. Overview
20.1.1. Market Dynamics for North America
20.1.1.1. Drivers
20.1.1.2. Restraints
20.1.1.3. Opportunities
20.1.1.4. Trends
20.2. Latin America In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2030(US$ Mn)
20.2.1. Overview
20.2.2. SRC Analysis
20.3. Latin America In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2030(US$ Mn)
20.3.1. Overview
20.3.2. SRC Analysis
20.4. Latin America In-Vitro Diagnostics (IVD) Market, by Application, 2017-2030(US$ Mn)
20.4.1. Overview
20.4.2. SRC Analysis
20.5. Latin America In-Vitro Diagnostics (IVD) Market, by End-User, 2017-2030(US$ Mn)
20.5.1. Overview
20.5.2. SRC Analysis
20.6. Latin America In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2030(US$ Mn)
20.6.1. Overview
20.6.2. SRC Analysis
20.7. Latin America In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2030(US$ Mn)
20.7.1. Overview
20.7.2. SRC Analysis
20.8. Latin America In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2030(US$ Mn)
20.8.1. Overview
20.8.2. SRC Analysis
20.9. Latin America In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2030(US$ Mn)
20.9.1. Overview
20.9.2. SRC Analysis
20.10. Latin America In-Vitro Diagnostics (IVD) Market, by Country, 2017-2032(US$ Mn)
20.10.1. Latin America In-Vitro Diagnostics (IVD) Market, by Country, 2023 Vs 2032 (in%)
20.10.2. Brazil
20.10.3. Argentina
20.10.4. Rest of Latin America
21. Middle East In-Vitro Diagnostics (IVD) Market Analysis
21.1. Overview
21.1.1. Market Dynamics for North America
21.1.1.1. Drivers
21.1.1.2. Restraints
21.1.1.3. Opportunities
21.1.1.4. Trends
21.2. Middle East In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2030(US$ Mn)
21.2.1. Overview
21.2.2. SRC Analysis
21.3. Middle East In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2030(US$ Mn)
21.3.1. Overview
21.3.2. SRC Analysis
21.4. Middle East In-Vitro Diagnostics (IVD) Market, by Application, 2017-2030(US$ Mn)
21.4.1. Overview
21.4.2. SRC Analysis
21.5. Middle East In-Vitro Diagnostics (IVD) Market, by End-User, 2017-2030(US$ Mn)
21.5.1. Overview
21.5.2. SRC Analysis
21.6. Middle East In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2030(US$ Mn)
21.6.1. Overview
21.6.2. SRC Analysis
21.7. Middle East In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2030(US$ Mn)
21.7.1. Overview
21.7.2. SRC Analysis
21.8. Middle East In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2030(US$ Mn)
21.8.1. Overview
21.8.2. SRC Analysis
21.9. Middle East In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2030(US$ Mn)
21.9.1. Overview
21.9.2. SRC Analysis
21.10. Middle East In-Vitro Diagnostics (IVD) Market, by Country, 2017-2032(US$ Mn)
21.10.1. Middle East In-Vitro Diagnostics (IVD) Market, by Country, 2023 Vs 2032 (in%)
21.10.2. UAE
21.10.3. Saudi Arabia
21.10.4. Rest of Middle East
22. Africa In-Vitro Diagnostics (IVD) Market Analysis
22.1. Overview
22.1.1. Market Dynamics for North America
22.1.1.1. Drivers
22.1.1.2. Restraints
22.1.1.3. Opportunities
22.1.1.4. Trends
22.2. Africa In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2030(US$ Mn)
22.2.1. Overview
22.2.2. SRC Analysis
22.3. Africa In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2030(US$ Mn)
22.3.1. Overview
22.3.2. SRC Analysis
22.4. Africa In-Vitro Diagnostics (IVD) Market, by Application, 2017-2030(US$ Mn)
22.4.1. Overview
22.4.2. SRC Analysis
22.5. Africa In-Vitro Diagnostics (IVD) Market, by End-User, 2017-2030(US$ Mn)
22.5.1. Overview
22.5.2. SRC Analysis
22.6. Africa In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2030(US$ Mn)
22.6.1. Overview
22.6.2. SRC Analysis
22.7. Africa In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2030(US$ Mn)
22.7.1. Overview
22.7.2. SRC Analysis
22.8. Africa In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2030(US$ Mn)
22.8.1. Overview
22.8.2. SRC Analysis
22.9. Africa In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2030(US$ Mn)
22.9.1. Overview
22.9.2. SRC Analysis
22.10. Africa In-Vitro Diagnostics (IVD) Market, by Country, 2017-2032(US$ Mn)
22.10.1. Middle East In-Vitro Diagnostics (IVD) Market, by Country, 2023 Vs 2032 (in%)
22.10.2. South Africa
22.10.3. Egypt
22.10.4. Rest of Africa
23. Company Profiles
23.1. Invitae Corporation
23.1.1. Company Overview
23.1.2. Products/Services Portfolio
23.1.3. Geographical Presence
23.1.4. SWOT Analysis
23.1.5. Financial Summary
23.1.5.1. Market Revenue and Net Profit (2019-2022)
23.1.5.2. Business Segment Revenue Analysis
23.1.5.3. Geographical Revenue Analysis
23.2. Freenome Holdings, Inc.
23.3. Natera, Inc.
23.4. F. Hoffmann-La Roche Ltd.
23.5. InterVenn Biosciences
23.6. Guardant Health
23.7. Agilent Technologies, Inc.
23.8. Exact Sciences Corporation
23.9. Illumina, Inc.
23.10. NeoGenomics Laboratories
23.11. Thermo Fisher Scientific, Inc.
24. Research Methodology
24.1. Research Methodology
24.2. Phase I – Secondary Research
24.3. Phase II – Data Modelling
24.3.1. Company Share Analysis Model
24.3.2. Revenue Based Modelling
24.4. Phase III – Primary Research
24.5. Research Limitations
24.5.1. Assumptions

List of Figures
FIG. 1 Global In-Vitro Diagnostics (IVD) Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global In-Vitro Diagnostics (IVD) Market Segmentation
FIG. 4 Global In-Vitro Diagnostics (IVD) Market, by Product Type, 2023 (US$ Mn)
FIG. 5 Global In-Vitro Diagnostics (IVD) Market, by Technology, 2023 (US$ Mn)
FIG. 6 Global In-Vitro Diagnostics (IVD) Market, by Application, 2023 (US$ Mn)
FIG. 7 Global In-Vitro Diagnostics (IVD) Market, by Data Trasnfer Speed, 2023 (US$ Mn)
FIG. 8 Global In-Vitro Diagnostics (IVD) Market, by Usability, 2023 (US$ Mn)
FIG. 9 Global In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023 (US$ Mn)
FIG. 10 Global In-Vitro Diagnostics (IVD) Market, by Automation, 2023 (US$ Mn)
FIG. 11 Global In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023 (US$ Mn)
FIG. 12 Global In-Vitro Diagnostics (IVD) Market, by Geography, 2023 (US$ Mn)
FIG. 13 Attractive Investment Proposition, by Product Type, 2022
FIG. 14 Attractive Investment Proposition, by Technology, 2022
FIG. 15 Attractive Investment Proposition, by Application, 2022
FIG. 16 Attractive Investment Proposition, by End-User, 2022
FIG. 17 Attractive Investment Proposition, by Usability, 2022
FIG. 18 Attractive Investment Proposition, by Type of Sample, 2022
FIG. 19 Attractive Investment Proposition, by Automation, 2022
FIG. 20 Attractive Investment Proposition, by Point-of-Care Testing (POCT), 2022
FIG. 21 Attractive Investment Proposition, by Geography, 2022
FIG. 22 Global Market Share Analysis of Key In-Vitro Diagnostics (IVD) Market Manufacturers, 2022
FIG. 23 Global Market Positioning of Key In-Vitro Diagnostics (IVD) Market Manufacturers, 2022
FIG. 24 Global In-Vitro Diagnostics (IVD) Market Value Contribution, By Product Type, 2023 & 2032(Value %)
FIG. 25 Global In-Vitro Diagnostics (IVD) Market, by REAGENTS AND KITS, Value, 2017-2032(US$ Mn)
FIG. 26 Global In-Vitro Diagnostics (IVD) Market, by INSTRUMENTS, Value, 2017-2032(US$ Mn)
FIG. 27 Global In-Vitro Diagnostics (IVD) Market, by Data Management Software, Value, 2017-2032(US$ Mn)
FIG. 28 Global In-Vitro Diagnostics (IVD) Market Value Contribution, By Technology, 2023 & 2032(Value %)
FIG. 29 Global In-Vitro Diagnostics (IVD) Market, by Clinical Chemistry, Value, 2017-2032(US$ Mn)
FIG. 30 Global In-Vitro Diagnostics (IVD) Market, by Immunoassay/Immunochemistry, Value, 2017-2032(US$ Mn)
FIG. 31 Global In-Vitro Diagnostics (IVD) Market, by Molecular Diagnostics, Value, 2017-2032(US$ Mn)
FIG. 32 Global In-Vitro Diagnostics (IVD) Market, by Hematologys, Value, 2017-2032(US$ Mn)
FIG. 33 Global In-Vitro Diagnostics (IVD) Market, by Coagulation and Hemostasis, Value, 2017-2032(US$ Mn)
FIG. 34 Global In-Vitro Diagnostics (IVD) Market, by Microbiology, Value, 2017-2032(US$ Mn)
FIG. 35 Global In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), Value, 2017-2032(US$ Mn)
FIG. 36 Global In-Vitro Diagnostics (IVD) Market, by Others, Value, 2017-2032(US$ Mn)
FIG. 37 Global In-Vitro Diagnostics (IVD) Market Value Contribution, By Application, 2023 & 2032(Value %)
FIG. 38 Global In-Vitro Diagnostics (IVD) Market, by Infectious Disease Testing, Value, 2017-2032(US$ Mn)
FIG. 39 Global In-Vitro Diagnostics (IVD) Market, by Oncology/Cancer Testing, Value, 2017-2032(US$ Mn)
FIG. 40 Global In-Vitro Diagnostics (IVD) Market, by Diabetes Testing, Value, 2017-2032(US$ Mn)
FIG. 41 Global In-Vitro Diagnostics (IVD) Market, by Cardiology Testing, Value, 2017-2032(US$ Mn)
FIG. 42 Global In-Vitro Diagnostics (IVD) Market, by Nephrology Testing, Value, 2017-2032(US$ Mn)
FIG. 43 Global In-Vitro Diagnostics (IVD) Market, by Autoimmune Disease Testing, Value, 2017-2032(US$ Mn)
FIG. 44 Global In-Vitro Diagnostics (IVD) Market, by Drug Testing/Pharmacogenomics, Value, 2017-2032(US$ Mn)
FIG. 45 Global In-Vitro Diagnostics (IVD) Market, by Others, Value, 2017-2032(US$ Mn)
FIG. 46 Global In-Vitro Diagnostics (IVD) Market Value Contribution, By End-User, 2023 & 2032(Value %)
FIG. 47 Global In-Vitro Diagnostics (IVD) Market, by Hospitals and Clinics, Value, 2017-2032(US$ Mn)
FIG. 48 Global In-Vitro Diagnostics (IVD) Market, by Diagnostic Laboratories, Value, 2017-2032(US$ Mn)
FIG. 49 Global In-Vitro Diagnostics (IVD) Market, by Academic and Research Institutes, Value, 2017-2032(US$ Mn)
FIG. 50 Global In-Vitro Diagnostics (IVD) Market, by Home Care, Value, 2017-2032(US$ Mn)
FIG. 51 Global In-Vitro Diagnostics (IVD) Market, by Others, Value, 2017-2032(US$ Mn)
FIG. 52 Global In-Vitro Diagnostics (IVD) Market Value Contribution, By Usability, 2023 & 2032(Value %)
FIG. 53 Global In-Vitro Diagnostics (IVD) Market, by Disposable IVD Devices, Value, 2017-2032(US$ Mn)
FIG. 54 Global In-Vitro Diagnostics (IVD) Market, by Reusable IVD Devices, Value, 2017-2032(US$ Mn)
FIG. 55 Global In-Vitro Diagnostics (IVD) Market Value Contribution, By Type of Sample, 2023 & 2032(Value %)
FIG. 56 Global In-Vitro Diagnostics (IVD) Market, by Blood Testing, Value, 2017-2032(US$ Mn)
FIG. 57 Global In-Vitro Diagnostics (IVD) Market, by Urine Testing, Value, 2017-2032(US$ Mn)
FIG. 58 Global In-Vitro Diagnostics (IVD) Market, by Cerebrospinal Fluid (CSF) Testing, Value, 2017-2032(US$ Mn)
FIG. 59 Global In-Vitro Diagnostics (IVD) Market, by Saliva Testing, Value, 2017-2032(US$ Mn)
FIG. 60 Global In-Vitro Diagnostics (IVD) Market, by Others, Value, 2017-2032(US$ Mn)
FIG. 61 Global In-Vitro Diagnostics (IVD) Market Value Contribution, By Automation, 2023 & 2032(Value %)
FIG. 62 Global In-Vitro Diagnostics (IVD) Market, by Fully Automated IVD Systems, Value, 2017-2032(US$ Mn)
FIG. 63 Global In-Vitro Diagnostics (IVD) Market, by Semi-Automated IVD Systems, Value, 2017-2032(US$ Mn)
FIG. 64 Global In-Vitro Diagnostics (IVD) Market Value Contribution, By Point-of-Care Testing (POCT), 2023 & 2032(Value %)
FIG. 65 Global In-Vitro Diagnostics (IVD) Market, by Glucose Monitoring, Value, 2017-2032(US$ Mn)
FIG. 66 Global In-Vitro Diagnostics (IVD) Market, by Pregnancy and Fertility Testing, Value, 2017-2032(US$ Mn)
FIG. 67 Global In-Vitro Diagnostics (IVD) Market, by Infectious Disease POCT, Value, 2017-2032(US$ Mn)
FIG. 68 Global In-Vitro Diagnostics (IVD) Market, by Cardiac Markers POCT, Value, 2017-2032(US$ Mn)
FIG. 69 Global In-Vitro Diagnostics (IVD) Market, by Others, Value, 2017-2032(US$ Mn)
FIG. 70 North America In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 71 U.S. In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 72 Canada In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 73 Mexico In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 74 Europe In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 75 Germany In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 76 France In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 77 U.K. In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 78 Italy In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 79 Spain In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 80 Benelux In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 81 Russia In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 82 Rest of Europe In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 83 Asia Pacific In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 84 China In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 85 Japan In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 86 India In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 87 South Korea In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 88 South-East Asia In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 89 Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 90 Latin America In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 91 Brazil In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 92 Argentina In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 93 Rest of Latin America In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 94 Middle East In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 95 UAE In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 96 Saudi Arabia In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 97 Rest of Middle East In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 98 Africa In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 99 South Africa In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 100 Egypt In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)
FIG. 101 Rest of Africa In-Vitro Diagnostics (IVD) Market, 2017-2032(US$ Mn)

List of Tables
TABLE 1 Market Snapshot: Global In-Vitro Diagnostics (IVD) Market
TABLE 2 Global In-Vitro Diagnostics (IVD) Market: Market Drivers Impact Analysis
TABLE 3 Global In-Vitro Diagnostics (IVD) Market: Market Restraints Impact Analysis
TABLE 4 Global In-Vitro Diagnostics (IVD) Market, by Competitive Benchmarking, 2022
TABLE 5 Global In-Vitro Diagnostics (IVD) Market, by Geographical Presence Analysis, 2022
TABLE 6 Global In-Vitro Diagnostics (IVD) Market, by Key Strategies Analysis, 2022
TABLE 7 Global In-Vitro Diagnostics (IVD) Market, by REAGENTS AND KITS, By Region, 2017-2023 (US$ Mn)
TABLE 8 Global In-Vitro Diagnostics (IVD) Market, by REAGENTS AND KITS, By Region, 2023-2032(US$ Mn)
TABLE 9 Global In-Vitro Diagnostics (IVD) Market, by INSTRUMENTS, By Region, 2017-2023 (US$ Mn)
TABLE 10 Global In-Vitro Diagnostics (IVD) Market, by INSTRUMENTS, By Region, 2023-2032(US$ Mn)
TABLE 11 Global In-Vitro Diagnostics (IVD) Market, by Data Management Software, By Region, 2017-2023 (US$ Mn)
TABLE 12 Global In-Vitro Diagnostics (IVD) Market, by Data Management Software, By Region, 2023-2032(US$ Mn)
TABLE 13 Global In-Vitro Diagnostics (IVD) Market, by Clinical Chemistry, By Region, 2017-2023 (US$ Mn)
TABLE 14 Global In-Vitro Diagnostics (IVD) Market, by Clinical Chemistry, By Region, 2023-2032(US$ Mn)
TABLE 15 Global In-Vitro Diagnostics (IVD) Market, by Immunoassay/Immunochemistry, By Region, 2017-2023 (US$ Mn)
TABLE 16 Global In-Vitro Diagnostics (IVD) Market, by Immunoassay/Immunochemistry, By Region, 2023-2032(US$ Mn)
TABLE 17 Global In-Vitro Diagnostics (IVD) Market, by Hematology, By Region, 2017-2023 (US$ Mn)
TABLE 18 Global In-Vitro Diagnostics (IVD) Market, by Hematology, By Region, 2023-2032(US$ Mn)
TABLE 19 Global In-Vitro Diagnostics (IVD) Market, by Coagulation and Hemostasis, By Region, 2017-2023 (US$ Mn)
TABLE 20 Global In-Vitro Diagnostics (IVD) Market, by Coagulation and Hemostasis, By Region, 2023-2032(US$ Mn)
TABLE 21 Global In-Vitro Diagnostics (IVD) Market, by Microbiology, By Region, 2017-2023 (US$ Mn)
TABLE 22 Global In-Vitro Diagnostics (IVD) Market, by Microbiology, By Region, 2023-2032(US$ Mn)
TABLE 23 Global In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), By Region, 2017-2023 (US$ Mn)
TABLE 24 Global In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), By Region, 2023-2032(US$ Mn)
TABLE 25 Global In-Vitro Diagnostics (IVD) Market, by Others, By Region, 2017-2023 (US$ Mn)
TABLE 26 Global In-Vitro Diagnostics (IVD) Market, by Others, By Region, 2023-2032(US$ Mn
TABLE 27 Global In-Vitro Diagnostics (IVD) Market, by Infectious Disease Testing, By Region, 2017-2023 (US$ Mn)
TABLE 28 Global In-Vitro Diagnostics (IVD) Market, by Infectious Disease Testing, By Region, 2023-2032(US$ Mn)
TABLE 29 Global In-Vitro Diagnostics (IVD) Market, by Oncology/Cancer Testing, By Region, 2017-2023 (US$ Mn)
TABLE 30 Global In-Vitro Diagnostics (IVD) Market, by Oncology/Cancer Testing, By Region, 2023-2032(US$ Mn)
TABLE 31 Global In-Vitro Diagnostics (IVD) Market, by Diabetes Testing, By Region, 2017-2023 (US$ Mn)
TABLE 32 Global In-Vitro Diagnostics (IVD) Market, by Diabetes Testing, By Region, 2023-2032(US$ Mn)
TABLE 33 Global In-Vitro Diagnostics (IVD) Market, by Cardiology Testing, By Region, 2017-2023 (US$ Mn)
TABLE 34 Global In-Vitro Diagnostics (IVD) Market, by Cardiology Testing, By Region, 2023-2032(US$ Mn)
TABLE 35 Global In-Vitro Diagnostics (IVD) Market, by Nephrology Testing, By Region, 2017-2023 (US$ Mn)
TABLE 36 Global In-Vitro Diagnostics (IVD) Market, by Nephrology Testing, By Region, 2023-2032(US$ Mn)
TABLE 37 Global In-Vitro Diagnostics (IVD) Market, by Autoimmune Disease Testing, By Region, 2017-2023 (US$ Mn)
TABLE 38 Global In-Vitro Diagnostics (IVD) Market, by Autoimmune Disease Testing, By Region, 2023-2032(US$ Mn)
TABLE 39 Global In-Vitro Diagnostics (IVD) Market, by Drug Testing/Pharmacogenomics, By Region, 2017-2023 (US$ Mn)
TABLE 40 Global In-Vitro Diagnostics (IVD) Market, by Drug Testing/Pharmacogenomics, By Region, 2023-2032(US$ Mn)
TABLE 41 Global In-Vitro Diagnostics (IVD) Market, by Others, By Region, 2017-2023 (US$ Mn)
TABLE 42 Global In-Vitro Diagnostics (IVD) Market, by Others, By Region, 2023-2032(US$ Mn)
TABLE 43 Global In-Vitro Diagnostics (IVD) Market, by Hospitals and Clinics, By Region, 2017-2023 (US$ Mn)
TABLE 44 Global In-Vitro Diagnostics (IVD) Market, by Hospitals and Clinics, By Region, 2023-2032(US$ Mn)
TABLE 45 Global In-Vitro Diagnostics (IVD) Market, by Diagnostic Laboratories, By Region, 2017-2023 (US$ Mn)
TABLE 46 Global In-Vitro Diagnostics (IVD) Market, by Diagnostic Laboratories, By Region, 2023-2032(US$ Mn)
TABLE 47 Global In-Vitro Diagnostics (IVD) Market, by Academic and Research Institutes, By Region, 2017-2023 (US$ Mn)
TABLE 48 Global In-Vitro Diagnostics (IVD) Market, by Academic and Research Institutes, By Region, 2023-2032(US$ Mn)
TABLE 49 Global In-Vitro Diagnostics (IVD) Market, by Home Care, By Region, 2017-2023 (US$ Mn)
TABLE 50 Global In-Vitro Diagnostics (IVD) Market, by Home Care, By Region, 2023-2032(US$ Mn)
TABLE 51 Global In-Vitro Diagnostics (IVD) Market, by Others, By Region, 2017-2023 (US$ Mn)
TABLE 52 Global In-Vitro Diagnostics (IVD) Market, by Others, By Region, 2023-2032(US$ Mn)
TABLE 53 Global In-Vitro Diagnostics (IVD) Market, by Disposable IVD Devices, By Region, 2017-2023 (US$ Mn)
TABLE 54 Global In-Vitro Diagnostics (IVD) Market, by Disposable IVD Devices, By Region, 2023-2032(US$ Mn)
TABLE 55 Global In-Vitro Diagnostics (IVD) Market, by Reusable IVD Devices, By Region, 2017-2023 (US$ Mn)
TABLE 56 Global In-Vitro Diagnostics (IVD) Market, by Reusable IVD Devices, By Region, 2023-2032(US$ Mn)
TABLE 57 Global In-Vitro Diagnostics (IVD) Market, by Blood Testing, By Region, 2017-2023 (US$ Mn)
TABLE 58 Global In-Vitro Diagnostics (IVD) Market, by Blood Testing, By Region, 2023-2032(US$ Mn)
TABLE 59 Global In-Vitro Diagnostics (IVD) Market, by Urine Testing, By Region, 2017-2023 (US$ Mn)
TABLE 60 Global In-Vitro Diagnostics (IVD) Market, by Urine Testing, By Region, 2023-2032(US$ Mn)
TABLE 61 Global In-Vitro Diagnostics (IVD) Market, by Cerebrospinal Fluid (CSF) Testing, By Region, 2017-2023 (US$ Mn)
TABLE 62 Global In-Vitro Diagnostics (IVD) Market, by Cerebrospinal Fluid (CSF) Testing, By Region, 2023-2032(US$ Mn)
TABLE 63 Global In-Vitro Diagnostics (IVD) Market, by Saliva Testing, By Region, 2017-2023 (US$ Mn)
TABLE 64 Global In-Vitro Diagnostics (IVD) Market, by Saliva Testing, By Region, 2023-2032(US$ Mn)
TABLE 65 Global In-Vitro Diagnostics (IVD) Market, by Others, By Region, 2017-2023 (US$ Mn)
TABLE 66 Global In-Vitro Diagnostics (IVD) Market, by Others, By Region, 2023-2032(US$ Mn)
TABLE 67 Global In-Vitro Diagnostics (IVD) Market, by Fully Automated IVD Systems, By Region, 2017-2023 (US$ Mn)
TABLE 68 Global In-Vitro Diagnostics (IVD) Market, by Fully Automated IVD Systems, By Region, 2023-2032(US$ Mn)
TABLE 69 Global In-Vitro Diagnostics (IVD) Market, by Semi-Automated IVD Systems, By Region, 2017-2023 (US$ Mn)
TABLE 70 Global In-Vitro Diagnostics (IVD) Market, by Semi-Automated IVD Systems, By Region, 2023-2032(US$ Mn)
TABLE 71 Global In-Vitro Diagnostics (IVD) Market, by Glucose Monitoring, By Region, 2017-2023 (US$ Mn)
TABLE 72 Global In-Vitro Diagnostics (IVD) Market, by Glucose Monitoring, By Region, 2023-2032(US$ Mn)
TABLE 73 Global In-Vitro Diagnostics (IVD) Market, by Pregnancy and Fertility Testing, By Region, 2017-2023 (US$ Mn)
TABLE 74 Global In-Vitro Diagnostics (IVD) Market, by Pregnancy and Fertility Testing, By Region, 2023-2032(US$ Mn)
TABLE 75 Global In-Vitro Diagnostics (IVD) Market, by Infectious Disease POCT, By Region, 2017-2023 (US$ Mn)
TABLE 76 Global In-Vitro Diagnostics (IVD) Market, by Infectious Disease POCT, By Region, 2023-2032(US$ Mn)
TABLE 77 Global In-Vitro Diagnostics (IVD) Market, by Cardiac Markers POCT, By Region, 2017-2023 (US$ Mn)
TABLE 78 Global In-Vitro Diagnostics (IVD) Market, by Cardiac Markers POCT, By Region, 2023-2032(US$ Mn)
TABLE 79 Global In-Vitro Diagnostics (IVD) Market, by Others, By Region, 2017-2023 (US$ Mn)
TABLE 80 Global In-Vitro Diagnostics (IVD) Market, by Others, By Region, 2023-2032(US$ Mn)
TABLE 81 Global In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 82 Global In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 83 Global In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 84 Global In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 85 Global In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 86 Global In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 87 Global In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 88 Global In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 89 Global In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 90 Global In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 91 Global In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 92 Global In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 93 Global In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 94 Global In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 95 Global In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 96 Global In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 97 Global In-Vitro Diagnostics (IVD) Market, by Region, 2017-2023 (US$ Mn)
TABLE 98 Global In-Vitro Diagnostics (IVD) Market, by Region, 2023-2032(US$ Mn)
TABLE 99 North America In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 100 North America In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 101 North America In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 102 North America In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 103 North America In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 104 North America In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 105 North America In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 106 North America In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 107 North America In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 108 North America In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 109 North America In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 110 North America In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 111 North America In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 112 North America In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 113 North America In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 114 North America In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 115 North America In-Vitro Diagnostics (IVD) Market, by Country, 2017-2023 (US$ Mn)
TABLE 116 North America In-Vitro Diagnostics (IVD) Market, by Country, 2023-2032(US$ Mn)
TABLE 117 United States In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 118 United States In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 119 United States In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 120 United States In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 121 United States In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 122 United States In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 123 United States In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 124 United States In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 125 United States In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 126 United States In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 127 United States In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 128 United States In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 129 United States In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 130 United States In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 131 United States In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 132 United States In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 133 Canada In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 134 Canada In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 135 Canada In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 136 Canada In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 137 Canada In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 138 Canada In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 139 Canada In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 140 Canada In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 141 Canada In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 142 Canada In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 143 Canada In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 144 Canada In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 145 Canada In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 146 Canada In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 147 Canada In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 148 Canada In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 149 Mexico In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 150 Mexico In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 151 Mexico In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 152 Mexico In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 153 Mexico In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 154 Mexico In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 155 Mexico In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 156 Mexico In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 157 Mexico In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 158 Mexico In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 159 Mexico In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 160 Mexico In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 161 Mexico In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 162 Mexico In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 163 Mexico In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 164 Mexico In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 165 Europe In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 166 Europe In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 167 Europe In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 168 Europe In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 169 Europe In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 170 Europe In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 171 Europe In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 172 Europe In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 173 Europe In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 174 Europe In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 175 Europe In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 176 Europe In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 177 Europe In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 178 Europe In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 179 Europe In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 180 Europe In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 181 Europe In-Vitro Diagnostics (IVD) Market, by Country, 2017-2023 (US$ Mn)
TABLE 182 Europe In-Vitro Diagnostics (IVD) Market, by Country, 2023-2032(US$ Mn)
TABLE 183 Germany In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 184 Germany In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 185 Germany In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 186 Germany In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 187 Germany In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 188 Germany In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 189 Germany In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 190 Germany In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 191 Germany In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 192 Germany In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 193 Germany In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 194 Germany In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 195 Germany In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 196 Germany In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 197 Germany In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 198 Germany In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 199 France In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 200 France In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 201 France In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 202 France In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 203 France In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 204 France In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 205 France In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 206 France In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 207 France In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 208 France In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 209 France In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 210 France In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 211 France In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 212 France In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 213 France In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 214 France In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 215 United Kingdom In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 216 United Kingdom In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 217 United Kingdom In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 218 United Kingdom In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 219 United Kingdom In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 220 United Kingdom In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 221 United Kingdom In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 222 United Kingdom In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 223 United Kingdom In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 224 United Kingdom In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 225 United Kingdom In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 226 United Kingdom In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 227 United Kingdom In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 228 United Kingdom In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 229 United Kingdom In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 230 United Kingdom In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 231 Italy In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 232 Italy In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 233 Italy In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 234 Italy In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 235 Italy In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 236 Italy In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 237 Italy In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 238 Italy In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 239 Italy In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 240 Italy In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 241 Italy In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 242 Italy In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 243 Italy In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 244 Italy In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 245 Italy In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 246 Italy In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 247 Spain In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 248 Spain In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 249 Spain In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 250 Spain In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 251 Spain In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 252 Spain In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 253 Spain In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 254 Spain In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 255 Spain In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 256 Spain In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 257 Spain In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 258 Spain In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 259 Spain In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 260 Spain In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 261 Spain In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 262 Spain In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 263 Benelux In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 264 Benelux In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 265 Benelux In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 266 Benelux In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 267 Benelux In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 268 Benelux In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 269 Benelux In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 270 Benelux In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 271 Benelux In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 272 Benelux In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 273 Benelux In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 274 Benelux In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 275 Benelux In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 276 Benelux In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 277 Benelux In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 278 Benelux In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 279 Russia In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 280 Russia In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 281 Russia In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 282 Russia In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 283 Russia In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 284 Russia In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 285 Russia In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 286 Russia In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 287 Russia In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 288 Russia In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 289 Russia In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 290 Russia In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 291 Russia In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 292 Russia In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 293 Russia In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 294 Russia In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 295 Rest of Europe In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 296 Rest of Europe In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 297 Rest of Europe In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 298 Rest of Europe In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 299 Rest of Europe In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 300 Rest of Europe In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 301 Rest of Europe In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 302 Rest of Europe In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 303 Rest of Europe In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 304 Rest of Europe In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 305 Rest of Europe In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 306 Rest of Europe In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 307 Rest of Europe In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 308 Rest of Europe In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 309 Rest of Europe In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 310 Rest of Europe In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 311 Asia Pacific In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 312 Asia Pacific In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 313 Asia Pacific In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 314 Asia Pacific In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 315 Asia Pacific In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 316 Asia Pacific In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 317 Asia Pacific In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 318 Asia Pacific In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 319 Asia Pacific In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 320 Asia Pacific In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 321 Asia Pacific In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 322 Asia Pacific In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 323 Asia Pacific In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 324 Asia Pacific In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 325 Asia Pacific In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 326 Asia Pacific In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 327 China In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 328 China In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 329 China In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 330 China In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 331 China In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 332 China In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 333 China In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 334 China In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 335 China In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 336 China In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 337 China In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 338 China In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 339 China In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 340 China In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 341 China In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 342 China In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 343 Japan In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 344 Japan In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 345 Japan In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 346 Japan In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 347 Japan In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 348 Japan In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 349 Japan In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 350 Japan In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 351 Japan In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 352 Japan In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 353 Japan In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 354 Japan In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 355 Japan In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 356 Japan In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 357 Japan In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 358 Japan In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 359 India In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 360 India In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 361 India In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 362 India In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 363 India In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 364 India In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 365 India In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 366 India In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 367 India In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 368 India In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 369 India In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 370 India In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 371 India In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 372 India In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 373 India In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 374 India In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 375 South Korea In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 376 South Korea In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 377 South Korea In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 378 South Korea In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 379 South Korea In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 380 South Korea In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 381 South Korea In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 382 South Korea In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 383 South Korea In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 384 South Korea In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 385 South Korea In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 386 South Korea In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 387 South Korea In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 388 South Korea In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 389 South Korea In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 390 South Korea In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 391 South-East Asia In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 392 South-East Asia In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 393 South-East Asia In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 394 South-East Asia In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 395 South-East Asia In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 396 South-East Asia In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 397 South-East Asia In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 398 South-East Asia In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 399 South-East Asia In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 400 South-East Asia In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 401 South-East Asia In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 402 South-East Asia In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 403 South-East Asia In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 404 South-East Asia In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 405 South-East Asia In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 406 South-East Asia In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 407 Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 408 Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 409 Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 410 Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 411 Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 412 Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 413 Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 414 Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 415 Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 416 Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 417 Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 418 Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 419 Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 420 Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 421 Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 422 Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 423 Latin America In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 424 Latin America In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 425 Latin America In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 426 Latin America In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 427 Latin America In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 428 Latin America In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 429 Latin America In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 430 Latin America In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 431 Latin America In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 432 Latin America In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 433 Latin America In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 434 Latin America In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 435 Latin America In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 436 Latin America In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 437 Latin America In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 438 Latin America In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 439 Brazil In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 440 Brazil In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 441 Brazil In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 442 Brazil In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 443 Brazil In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 444 Brazil In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 445 Brazil In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 446 Brazil In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 447 Brazil In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 448 Brazil In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 449 Brazil In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 450 Brazil In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 451 Brazil In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 452 Brazil In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 453 Brazil In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 454 Brazil In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 455 Argentina In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 456 Argentina In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 457 Argentina In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 458 Argentina In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 459 Argentina In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 460 Argentina In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 461 Argentina In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 462 Argentina In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 463 Argentina In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 464 Argentina In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 465 Argentina In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 466 Argentina In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 467 Argentina In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 468 Argentina In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 469 Argentina In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 470 Argentina In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 471 Rest of Latin America In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 472 Rest of Latin America In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 473 Rest of Latin America In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 474 Rest of Latin America In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 475 Rest of Latin America In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 476 Rest of Latin America In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 477 Rest of Latin America In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 478 Rest of Latin America In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 479 Rest of Latin America In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 480 Rest of Latin America In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 481 Rest of Latin America In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 482 Rest of Latin America In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 483 Rest of Latin America In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 484 Rest of Latin America In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 485 Rest of Latin America In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 486 Rest of Latin America In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 487 Middle East In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 488 Middle East In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 489 Middle East In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 490 Middle East In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 491 Middle East In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 492 Middle East In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 493 Middle East In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 494 Middle East In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 495 Middle East In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 496 Middle East In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 497 Middle East In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 498 Middle East In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 499 Middle East In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 500 Middle East In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 501 Middle East In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 502 Middle East In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 503 UAE In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 504 UAE In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 505 UAE In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 506 UAE In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 507 UAE In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 508 UAE In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 509 UAE In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 510 UAE In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 511 UAE In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 512 UAE In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 513 UAE In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 514 UAE In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 515 UAE In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 516 UAE In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 517 UAE In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 518 UAE In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 519 Saudi Arabia In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 520 Saudi Arabia In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 521 Saudi Arabia In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 522 Saudi Arabia In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 523 Saudi Arabia In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 524 Saudi Arabia In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 525 Saudi Arabia In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 526 Saudi Arabia In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 527 Saudi Arabia In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 528 Saudi Arabia In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 529 Saudi Arabia In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 530 Saudi Arabia In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 531 Saudi Arabia In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 532 Saudi Arabia In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 533 Saudi Arabia In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 534 Saudi Arabia In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 535 Rest of Middle East In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 536 Rest of Middle East In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 537 Rest of Middle East In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 538 Rest of Middle East In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 539 Rest of Middle East In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 540 Rest of Middle East In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 541 Rest of Middle East In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 542 Rest of Middle East In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 543 Rest of Middle East In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 544 Rest of Middle East In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 545 Rest of Middle East In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 546 Rest of Middle East In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 547 Rest of Middle East In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 548 Rest of Middle East In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 549 Rest of Middle East In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 550 Rest of Middle East In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 551 Africa In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 552 Africa In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 553 Africa In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 554 Africa In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 555 Africa In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 556 Africa In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 557 Africa In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 558 Africa In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 559 Africa In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 560 Africa In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 561 Africa In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 562 Africa In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 563 Africa In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 564 Africa In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 565 Africa In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 566 Africa In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 567 South Africa In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 568 South Africa In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 569 South Africa In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 570 South Africa In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 571 South Africa In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 572 South Africa In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 573 South Africa In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 574 South Africa In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 575 South Africa In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 576 South Africa In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 577 South Africa In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 578 South Africa In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 579 South Africa In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 580 South Africa In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 581 South Africa In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 582 South Africa In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 583 Egypt In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 584 Egypt In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 585 Egypt In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 586 Egypt In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 587 Egypt In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 588 Egypt In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 589 Egypt In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 590 Egypt In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 591 Egypt In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 592 Egypt In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 593 Egypt In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 594 Egypt In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 595 Egypt In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 596 Egypt In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)
TABLE 597 Egypt In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 598 Egypt In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)
TABLE 599 Rest of Africa In-Vitro Diagnostics (IVD) Market, by Product Type, 2017-2023 (US$ Mn)
TABLE 600 Rest of Africa In-Vitro Diagnostics (IVD) Market, by Product Type, 2023-2032(US$ Mn)
TABLE 601 Rest of Africa In-Vitro Diagnostics (IVD) Market, by Technology, 2017-2023 (US$ Mn)
TABLE 602 Rest of Africa In-Vitro Diagnostics (IVD) Market, by Technology, 2023-2032(US$ Mn)
TABLE 603 Rest of Africa In-Vitro Diagnostics (IVD) Market, by Application, 2017-2023 (US$ Mn)
TABLE 604 Rest of Africa In-Vitro Diagnostics (IVD) Market, by Application, 2023-2032(US$ Mn)
TABLE 605 Rest of Africa In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2017-2023 (US$ Mn)
TABLE 606 Rest of Africa In-Vitro Diagnostics (IVD) Market, by End-User, By Region, 2023-2032(US$ Mn)
TABLE 607 Rest of Africa In-Vitro Diagnostics (IVD) Market, by Usability, 2017-2023 (US$ Mn)
TABLE 608 Rest of Africa In-Vitro Diagnostics (IVD) Market, by Usability, 2023-2032(US$ Mn)
TABLE 609 Rest of Africa In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2017-2023 (US$ Mn)
TABLE 610 Rest of Africa In-Vitro Diagnostics (IVD) Market, by Type of Sample, 2023-2032(US$ Mn)
TABLE 611 Rest of Africa In-Vitro Diagnostics (IVD) Market, by Automation, 2017-2023 (US$ Mn)
TABLE 612 Rest of Africa In-Vitro Diagnostics (IVD) Market, by Automation, 2023-2032(US$ Mn)

TABLE 613 Rest of Africa In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2017-2023 (US$ Mn)
TABLE 614 Rest of Africa In-Vitro Diagnostics (IVD) Market, by Point-of-Care Testing (POCT), 2023-2032(US$ Mn)

Frequently Asked Questions

What is the current size of the global In-Vitro Diagnostics (IVD) Market?

The global In-Vitro Diagnostics (IVD) Market was valued at USD 117545.8 Million in 2023.

What is the expected growth rate of the In-Vitro Diagnostics (IVD) Market between 2024 and 2032?

The In-Vitro Diagnostics (IVD) Market is expected to grow at a CAGR of 5.00% between 2024 and 2032, reaching USD 182352.1 Million in 2032.

Which segment is leading the market share in terms of End-User?

In 2023, the diagnostic laboratory end-use category led the global market

Which segment governs the demand for Type of Sample?

Blood testing is in higher demand in the In-Vitro Diagnostics (IVD) Market

Who are the major players in the global In-Vitro Diagnostics (IVD) Market?

The top players include Invitae Corporation, Freenome Holdings, Inc., Natera, Inc., F. Hoffmann-La Roche Ltd and Others.

Hot And Cold Therapy Packs Market

Published:
Report ID: 7187

Digital Therapeutics Market

Published:
Report ID: 5029

Needles Market

Published:
Report ID: 41010

Microbial Contract Biomanufacturing Market

Published:
Report ID: 41008

Medical Polymers Market

Published:
Report ID: 40983

Medical Exoskeleton Market

Published:
Report ID: 40982

Medical Drones Market

Published:
Report ID: 40981

Automatic Sampling Market

Published:
Report ID: 40979

Chromatography Consumables Market

Published:
Report ID: 40751

Cryopreservation Bags and Freezing Bags Market

Published:
Report ID: 40915

Europe Medical Device Contract Manufacturing Market

Published:
Report ID: 40558

Asia Pacific Medical Device Contract Manufacturing Market

Published:
Report ID: 40560

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN